Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

GRAND PHARMA (0512.HK)

Compare
5.600
-0.200
(-3.45%)
At close: 4:08:01 PM GMT+8
Currency in HKD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,644,892
11,644,892
10,529,590
9,562,285
8,597,975
Cost of Revenue
4,906,576
4,906,576
4,005,524
3,610,806
3,350,737
Gross Profit
6,738,316
6,738,316
6,524,066
5,951,479
5,247,238
Operating Expense
4,566,282
4,566,282
3,700,773
3,268,291
3,232,688
Operating Income
2,172,034
2,172,034
2,823,293
2,683,188
2,014,550
Net Non Operating Interest Income Expense
-173,932
-173,932
-197,400
-117,687
-18,011
Pretax Income
2,852,363
2,852,363
2,344,197
2,516,893
2,785,832
Tax Provision
386,304
386,304
448,755
418,642
380,800
Net Income Common Stockholders
2,468,375
2,468,375
1,879,998
2,079,419
2,402,563
Diluted NI Available to Com Stockholders
2,468,375
2,468,375
1,879,998
2,079,419
2,402,563
Basic EPS
0.69
0.70
0.54
0.59
0.68
Diluted EPS
0.69
0.70
0.54
0.59
0.68
Basic Average Shares
3,494,341
3,501,810
3,507,754
3,542,258
3,548,050
Diluted Average Shares
3,501,809.648
3,501,810
3,507,754
3,542,258
3,548,050
Rent Expense Supplemental
37,488
37,488
25,012
--
--
Total Expenses
9,472,858
9,472,858
7,706,297
6,879,097
6,583,425
Net Income from Continuing & Discontinued Operation
2,468,375
2,468,375
1,879,998
2,079,419
2,402,563
Normalized Income
1,952,292.638
1,952,292.638
1,903,962.844
2,192,012.325
1,991,198.303
Interest Income
6,310
6,310
7,745
19,806
74,953
Interest Expense
180,242
180,242
205,145
137,493
92,964
Net Interest Income
-173,932
-173,932
-197,400
-117,687
-18,011
EBIT
3,032,605
3,032,605
2,549,342
2,654,386
2,878,796
EBITDA
3,536,353
3,536,353
2,941,552
3,049,298
3,218,315
Reconciled Cost of Revenue
4,906,576
4,906,576
4,005,524
3,610,806
3,350,737
Reconciled Depreciation
503,748
503,748
392,210
394,912
339,519
Net Income from Continuing Operation Net Minority Interest
2,468,375
2,468,375
1,879,998
2,079,419
2,402,563
Total Unusual Items Excluding Goodwill
653,686
653,686
18,763
-91,345
476,498
Total Unusual Items
702,759
702,759
57,899
-54,903
476,498
Normalized EBITDA
2,833,594
2,833,594
2,883,653
3,104,201
2,741,817
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
88,530.638
88,530.638
3,591.844
-15,193.675
65,133.303
12/31/2021 - 5/11/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0867.HK CMS
7.400
-1.73%
 
0719.HK SHANDONG XINHUA
5.500
0.00%
 
3692.HK Hansoh Pharmaceutical Group Company Limited
22.150
-2.85%
 
3320.HK China Resources Pharmaceutical Group Limited
4.960
-1.20%
 
1061.HK ESSEX BIO-TECH
4.450
-3.05%
 
2186.HK Luye Pharma Group Ltd.
1.860
-1.06%
 
3933.HK The United Laboratories International Holdings Limited
13.380
+0.45%
 
1681.HK CONSUN PHARMA
9.630
-1.33%